ERYTHROMYCIN ESTOLATE MICRONIZED
Erythromycin micronized enhances dissolution and bioavailability for infection treatment. Side effects include nausea, cramps, and rash.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
Micronized erythromycin estolate features reduced particle size for enhanced dissolution and improved pharmacokinetics. Mechanism remains 50S ribosomal translocation inhibition, suppressing bacterial protein synthesis.
Benefits and Advantages
Used in dissolution‑rate studies, particle‑engineering research, macrolide‑PK modelling, and improved‑absorption formulation science.
Side Effects and Risks
Risks include liver enzyme elevation, cholestatic jaundice, abdominal discomfort and allergic reactions. Handle with micronized‑macrolide precautions.
Datasheet
| Molecular Formula | C40H73NO14 |
|---|---|
| Molecular Weight | 804.0 g/mol |
| CAS Number | 3521-72-8 |
| Storage Condition | Store in a cool, dry place; protect from light |
| Solubility | Soluble in water |
| Purity | Purity information is available upon request (COA). |
| IUPAC/Chemical Name | (3R,4S,5S,6R,7R,9R,11R,12R)-erythromycin lauryl sulfate ester |
| InChl Key | Unavailable |
| InChl Code | Unavailable |
| References | PubChem; ChemBL; FDA; |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.



